|
Volumn 345, Issue 10, 2001, Pages 725-730
|
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction
a,c b,c c c,d c,e c,f c,g c,h c,i c,j c,i |
Author keywords
[No Author keywords available]
|
Indexed keywords
FLUOROURACIL;
FOLINIC ACID;
ADULT;
AGED;
ARTICLE;
BLOOD TOXICITY;
BONE MARROW SUPPRESSION;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER SURGERY;
CANCER SURVIVAL;
CONTROLLED STUDY;
DIARRHEA;
FEMALE;
GASTRECTOMY;
GASTROINTESTINAL SYMPTOM;
HIGH RISK PATIENT;
HUMAN;
LOWER ESOPHAGUS SPHINCTER;
MAJOR CLINICAL STUDY;
MALE;
NAUSEA;
PATIENT SELECTION;
POSTOPERATIVE CARE;
PRIORITY JOURNAL;
RADIATION DOSE;
RISK ASSESSMENT;
STOMACH ADENOCARCINOMA;
TOXICITY;
TREATMENT OUTCOME;
VOMITING;
ADENOCARCINOMA;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIMETABOLITES, ANTINEOPLASTIC;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
ESOPHAGOGASTRIC JUNCTION;
FEMALE;
FLUOROURACIL;
GASTRECTOMY;
HUMANS;
LEUCOVORIN;
LYMPH NODE EXCISION;
MALE;
MIDDLE AGED;
RADIATION DOSAGE;
STOMACH NEOPLASMS;
SURVIVAL RATE;
|
EID: 0035818048
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMoa010187 Document Type: Article |
Times cited : (3172)
|
References (27)
|